Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: CASE
Total 0 results
Nothing found
Sponsors and Collaborators
UNITI Consortium
Cogniciti
The Affiliated Hospital of Xuzhou Medical University
Salena Killion
Shanghai GeneChem Co., Ltd.
Vivid Pharma Inc.
Defence Services Medical Academy (DSMA), Myanmar
Université de Genève (UNIGE)
NERv Technology Inc
BioNova Pharmaceuticals (Shanghai) LTD.
Nutrabolt
Pia Jaeger, MD, PhD
Impulse Dynamics, Inc.
Zhongda Hospital, Medical School, Southeast University
HBSA
Hungarian Dental Association
Ministry of Public Health, Cameroon
Health Information Technology Solutions (HITS) LLC
Huisartspraktijk Handellaan
Smart Meter Corporation
View Full List
Medical Conditions
Biomarkers, Pharmacological
Vertebral Compression Fractures in Osteoporotic Patients
Infection, Bacterial
Old Age (Focus; Not a Recognized Condition)
VEXAS Syndrome
Advanced Bladder Carcinoma
Immediate Implant Placement
Failed Induction
Alzheimer Disease Focal
Cerebral Arterial Disease
Research Mentoring Skills
PPA Syndrome
Endoleaks
PET-CT Specimen Imager
Radiofrequency Ablation Treatment
SMA - Spinal Muscular Atrophy
Cardiovascular Primary Prevention
Premature Rupture of Membranes Prolonged
Pain, Breakthrough
Eye Disease, Hereditary
View Full List
Drug Interventions
Phase B: Triplixam / Elestar HCT
INT-747
CJ-12420 200mg + Clarithromycin 500mg
0.75% Ropivacaine
Olopatadine hydrochloride 0.2%
HPN328
Cefadroxil until drain removal
Lacosamide
Acetylsalicylic acid
Microneedling with topical glycolic acid 35%.
CNTO 6785 50 mg
Durvalumab + chemotherapy treatment
18F-FDG
20 mg/kg IV FL-301
5 FU continuous
TQB2450
Rosuvastatin
OXP005
80% oxygen
Oxymorphone hydrochloride (HCl)
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Cyprus
Contract Research Organizations in Dominican Republic
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Ireland
Contract Research Organizations in Kuwait
Contract Research Organizations in Moldova
Contract Research Organizations in Mozambique
Contract Research Organizations in Philippines
Contract Research Organizations in Rwanda
Contract Research Organizations in Trinidad & Tobago
Contract Research Organizations in Uzbekistan
CRO list by country
CROs in Mozambique
SGS
All CROs in Mozambique
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe